Karen Madden, chief technology officer at MilliporeSigma, said the center would help the company “become the partner of choice” in a range of “Star Trek” technology products and services ...

with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Editor’s note: This article was updated on Oct. 18 to correct the cost and ...

Products that significantly reduce their environmental impact or align with other sustainability goals are marked as “Greener Alternative Products” in our portfolio, indicated by a green icon. Test ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany (Merck KGaA), invested $76 million to expand its antibody drug conjugate (ADC) manufacturing ...

Expansion to create 170 jobs at Bioconjugation Center of Excellence in St. Louis, Missouri ST. LOUIS, October 29, 2024--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business ...

The St. Louis facility produces antibody-drug conjugate therapies that target and kill tumor cells. MilliporeSigma announced a $76 million investment to expand manufacturing capabilities at a St ...

MilliporeSigma, the U.S. and Canada life sciences arm of Germany’s Merck KGaA, continued its march of manufacturing investments this year with plans to pump $76 million into expanding production ...

Expansion to create 170 jobs at Bioconjugation Center of Excellence in St. Louis, Missouri ST. LOUIS, October 29, 2024--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of ...

Millipore Sigma looks to meet the global demand for ADCs. To accomplish this feat, they’re upgrading 34,000 square feet of their facility to benefit multiple departments, including Process and ...